Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Alkermes (United States) | Researchclopedia

Back to institutions

Alkermes (United States)

Waltham, Massachusettscompany

748

Works

70,725

Citations

128

h-index

Top Research Topics

Schizophrenia research and treatment Opioid Use Disorder Treatment Treatment of Major Depression

Top Researchers

Derrick Bennett University of Oxford

465 works235,481 citationsh-index: 119

Recent Research

Acoustic Monitoring of Lubrication and Compaction Effects on Tablet Performance Using Broadband Acoustic Resonance Dissolution Spectroscopy

Raghu V. G. Peddapatla,M. Rizwan Ahmed,et al.

20260 citations

Bipolar Disorder and Treatment

Substance Abuse Treatment and Outcomes

Pharmaceutical studies and practices

Neurotransmitter Receptor Influence on Behavior

Cancer Immunotherapy and Biomarkers

Nerve injury and regeneration

Inhalation and Respiratory Drug Delivery

Neuropeptides and Animal Physiology

Receptor Mechanisms and Signaling

David A. Weitz Harvard University

1,267 works128,630 citationsh-index: 181

Berislav V. Zloković University of Southern California

505 works69,693 citationsh-index: 117

Henry R. Kranzler

896 works47,921 citationsh-index: 115

Franco Lombardo Roca

63 works37,564 citationsh-index: 34

Douglas H. Smith California University of Pennsylvania

347 works37,470 citationsh-index: 102

Vibrance-1: A Randomized Phase 2 Study Evaluating Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680) in Patients with Narcolepsy Type 1

G. Plazzi,Yves Dauvilliers,et al.

20260 citations

Improvement in the Severity of Narcolepsy Symptoms and Fatigue in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)

Y. Dauvilliers,RR Grunstein,et al.

20260 citations

A Phase 2, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of Alixorexton (ALKS 2680) in Patients With Idiopathic Hypersomnia: Study Design and Methods for Vibrance-3

D. Plante,R. Grunstein,et al.

20260 citations

Improvement in Patient-reported Cognitive Functioning in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)

G. Plazzi,Y. Dauvilliers,et al.

20260 citations

Lipid Droplets in Cancer: New Insights and Therapeutic Potential

Shriya Joshi,Chakravarthy Garlapati,et al.

20260 citations